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LETTERS TO THE EDITOR
Correspondence to Seymour Rosen, M.D., Department of Pathology,Concerns about KIM-1 as a Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston,
MA 02215, USA.
E-mail: srosen@caregroup.harvard.eduurinary biomarker for acute
REFERENCEStubular necrosis (ATN)
1. Han WK, Bailly V, Abichandani R, et al: Kidney injury molecule-1
(KIM-1): A novel biomarker for human renal proximal tubule in-
To the Editor: In a recent issue of Kidney International, jury. Kidney Int 62:237–244, 2002
2. Rosen S, Heyman SN: Difficulties in understanding human “acuteHan et al [1], regarding kidney injury molecule-1 (KIM-1)
tubular necrosis”: Limited data and flawed animal models. Kidneyas a urinary biomarker for human proximal tubule injury,
Int 60:1220–1224, 2001brequires clarification. First, the selection of biopsied pa-
tients with putative acute tubular necrosis (ATN) is prob-
lematic. The authors include “ischemia” with minimal Calciphylaxis is usuallychange, interstitial nephritis, and membranous nephropa-
thy [with nonsteroidal anti-inflammatory drugs (NSAIDs)] nonulcerating: Risk factors,and state that all patients had a confirmed pathologic
diagnosis of ATN. Interstitial nephritis, membranous ne- outcomes, and therapyphropathy (with NSAIDs), and minimal change disease
are not commonly associated with ATN. Even in renal
To the Editor: The paper on calciphylaxis by Fine andbiopsies done within days after transplantation, changes
Zacharias [1] in a recent issue of Kidney International didof overt tubular necrosis are usually very limited [2].
not describe the exact histopathologic findings on skinSecond, the expression of KIM-1 in these patients’
biopsy of their patients. The sine qua non of the disorderbiopsies, as illustrated in Figure 1B of Han et al’s article,
is medial calcinosis of the small arteries in the subcutisis in the proximal convoluted tubules (S1/S2) not the
[2, 3]. Progression leads to acute infarction of the subcuta-pars recta (S3), the tubule in which KIM-1 has been
neous adipose tissue [4].demonstrated in experimental ischemia reflow [1]. Fur-
The relevance of bone scan remains unclear. The expe-thermore, there are no biopsy controls from patients that
rience of the authors indicated that in two of their totalthe authors did not consider to have ATN.
eight patients, there was no uptake in “clinically obviousThird, the control group for urinary KIM-1 concentra-
areas” but uptake was present in distant organs liketion was much younger than patients with ATN. The urine
lungs. Yet, the conclusion was that bone scan was “almostcollections occurred at various times in relationship to
always positive.” In a patient with retained subcutaneouspeak creatinine and levels of KIM-1 were “normalized”
tissue underlying the affected cutaneous area, would nofor this variation. Can one correct for incremental differ-
uptake on bone scan exclude a diagnosis of calciphylaxis?ences in KIM-1 excretion without extensive data concern-
The authors advocated against skin biopsy. In fact,ing the pattern of excretion of this protein? Interestingly,
skin biopsy was done only in four patients. Is it possiblethe patient who underwent repair of an aortic aneurysm
that some of the patients who responded to prednisone(represented in Figure 4 of Han et al’s article) had very
might have had another dermatologic disease?high levels of urinary KIM-1 without clinical ATN.
Finally, the patients considered to have contrast ne-
Prem K.G. Chandranphropathy have limited KIM-1 excretion consistent with
Des Moines, Iowa
the experimental contrast nephropathy model showing
predominantly distal nephron injury [2]. This under- Correspondence to Prem K.G. Chandran, M.D., Nephrology Clinic,
1215 Pleasant, #100, Des Moines, Iowa 50309.scores the limitation of KIM-1 as a marker for ATN that
E-mail: pkgchandran@mchsi.commay involve nephron segments other than the proximal
tubule.
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Correspondence to Miguel Pe´rez Fonta´n, M.D., Division of Nephrol-
ogy, Hospital Juan Canalejo, Xubias 84, 15006 A Corun˜a, Spain.A comparison of transplant
REFERENCESoutcomes in peritoneal and
1. Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ: A comparison
of transplant outcomes in peritoneal and hemodialysis patients.hemodialysis patients Kidney Int 62:1423–1430, 2002
2. Bleyer AJ, Burkart JM, Russell GB, Adams PL: Dialysis mod-
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To the Editor: The recent study published in Kidney J Am Soc Nephrol 10:154–159, 1999
International by Snyder et al [1] examines the impact of
Reply from the Authorsdialysis modality at the time of renal transplant on the
outcome of the transplant intervention. Confirming pre- We disagree that our finding, that patients treated
vious reports [2], early graft function rates are signifi- with peritoneal dialysis versus hemodialysis have slightly
cantly better for peritoneal dialysis patients than for he- worse graft survival after kidney transplantation, is weakly
modialysis patients. Also, early graft function is disclosed supported by the data [1]. While the difference in the rate
as a significant predictor of graft survival. Somewhat of graft failure between these two groups is small, this
paradoxically, early graft survival appears to be signifi- finding, nevertheless, contradicts the hypothesis that early
cantly worse in peritoneal dialysis patients, a difference graft survival among peritoneal dialysis patients should
attributed to higher rates of graft thrombosis in this be better. The fact that the reduction in graft survival
group. among peritoneal dialysis patients was statistically sig-
The size of the sample and the amount of information nificant during the first 3 months, but not among patients
presented by the authors are really impressive, but the who survived at least 3 months, does not diminish the
main conclusion of the study is weakly supported by the importance of the finding.
presented data. The difference in graft survival between We disagree that differences are clearly significant
peritoneal dialysis and hemodialysis is small, well below only if deaths are censored. The effect of dialysis mod-
the limits that many would consider clinically significant. ality on outcome was seen for both death-censored and
In addition, this difference is statistically significant only overall graft failure. There was no effect on mortality,
in the first 3 months after transplantation, which sheds implying that most of the effect of dialysis modality on
further doubts on the real relevance of the results. Fi-
graft failure was due to its effect on death-censored graft
nally, statistical differences are clearly significant only if
failure.early demises are censored. Death in the first weeks after
We cannot tell from these data why peritoneal dialysistransplantation may be linked to graft dysfunction and,
patients have reduced graft survival, despite having lessin our opinion, death must be considered an instance of
delayed graft function. We can think of no plausiblegraft failure in this setting, to yield a more realistic view
reasons why there should be differences between theof the question.
two groups with respect to whether the right or leftEven if we accept the main conclusions of the study,
kidney was used (left was used 55% in both groups), orSnyder et al [1] do not provide an answer for the main
in the proportion of very young donors (donors 2 orquestion. Are their findings attributable to features spe-
5 were used in 1% and 2%, respectively, in bothcific to the mode of dialysis, or just the consequence of
groups). While there were minor differences in the typea disequilibrium in the distribution of other risk factors
of immunosuppression used in the two groups, adjustingfor graft thrombosis between both populations? The
for this did not change the effect of peritoneal dialysisstudy evaluates a wide set of covariables, but we miss
versus hemodialysis on graft survival.data that are essential to analyze this question (e.g.,
We can only speculate whether peritoneal dialysis pa-immunosuppression schedules, use of right versus left
tients may have had a higher prevalence of inheritedkidney, use of very-low age donors or, importantly, anal-
coagulopathies. Indeed, our observation that the higherysis of potential center effects or differences in the preva-
rate of graft failure may have been due to a higher ratelence of thrombophilic states between both populations).
of graft thrombosis must be tempered by the fact thatUnless these points are clarified, it cannot be discarded
only a subset of patients had data on the cause of graftthat the mode of dialysis may be simply a confusion
variable. failure and could be included in this analysis. Clearly,
